About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets

US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets

by Savitha C Muppala on Dec 2 2011 8:38 PM

US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets

Lupin Pharmaceuticals has received the nod from the US FDA for its Minocycline hydrochloride extended release tablets 45 mg, 55 mg, 90 mg and 135 mg strengths.

Lupin has also received tentative approval for its Minocycline HCI extended release tablets 65 mg, 80 mg, 105 mg and 115 mg strengths.

Acne - Causes Symptoms Diagnosis Treatment FAQs Videos Glossary Reference

Acne - Causes Symptoms Diagnosis Treatment FAQs Videos Glossary Reference
Acne vulgaris, popularly known as ‘pimples’ or ‘zits’ is a skin condition affecting most teenagers.

Solodyn is an oral antibiotic used in the treatment of red, pus-filled pimples and acne in patients 12 years of age and older.

Source-Medindia

About Gout

About Gout
High levels of uric acid in blood and recurring attacks of joint inflammation are the main symptoms of gout. Lifestyle changes like weight loss, increasing fluid intake and dietary changes can help.

Boils | Skin Abscess - Causes, Symptoms, Diagnosis, Treatment

Boils | Skin Abscess - Causes, Symptoms, Diagnosis, Treatment
Encyclopedia section of medindia gives general info about Boils / Skin Abscess

Anti-Aging Treatment with Vinotherapy or Wine Facials

Anti-Aging Treatment with Vinotherapy or Wine Facials
Experience the bliss of vinotherapy - the power of grapes for a kissable skin.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement